High urgency

TruHeight; Analysis of Proposed Consent Order To Aid Public Comment

Detected July 5, 2026 · in Dietary-Supplement Labeling (FDA)

The FTC proposed a consent order against TruHeight for deceptive advertising of dietary supplements, alleging unsubstantiated height increase claims. This signals heightened enforcement against structure/function claims lacking scientific evidence.

Aforeworn detected this change in the Dietary-Supplement Labeling (FDA) space on July 5, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated High urgency. Supplement brands, contract manufacturers, private-label sellers, ingredient suppliers should confirm how it applies to their specific situation before acting. There is a time constraint attached: Immediately; ongoing compliance monitoring.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Dietary-Supplement Labeling (FDA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.

What changed

FTC consent order sets precedent that growth-related claims for supplements require rigorous scientific substantiation; similar claims may trigger enforcement.

Who it affects

Supplement brands, contract manufacturers, private-label sellers, ingredient suppliers

What you must do

Review all product claims for growth, development, or performance benefits; ensure they are supported by competent and reliable scientific evidence.

Deadline

Immediately; ongoing compliance monitoring.

Source: https://www.federalregister.gov/documents/2026/04/15/2026-07333/truheight-analysis-of-proposed-consent-order-to-aid-public-comment

Never miss a change like this again

Aforeworn watches Dietary-Supplement Labeling (FDA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.

Start your free trial

Related changes in Dietary-Supplement Labeling (FDA)